Physician profile
Derek Riley
NPI 1295042976
$5,869.55
in general payments reported to CMS, 2019-2025
15 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $119 · 2022: $86.24 · 2023: $1,364 · 2024: $3,037 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,703 · Food and Beverage: $1,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,702.72 |
| Food and Beverage | $1,811.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,856.01 | 2019-2025 | Actishield, Blueprint Patient Specific Instrumentation, T2 Alpha |
| Smith+Nephew, INC. | $2,330.07 | 2022-2025 | Real Intelligence, Journey II, Legion Revision |
| Steelhead Surgical INC | $243.35 | 2023-2025 | |
| Abbott Laboratories | $113.93 | 2019-2024 | Proclaim |
| Restor3d, INC. | $113.17 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $36.14 | 2022 | |
| Left Coast Surgical INC | $35.02 | 2025 | |
| Biocomposites INC | $30.75 | 2025 | Stimulan |
| Solventum Corporation | $23.20 | 2024 | Prevena |
| Anika Therapeutics, INC. | $21.96 | 2022 | |
| Bioventus LLC | $15.60 | 2022 | |
| Heron Therapeutics, INC. | $14.65 | 2025 | Zynrelef |
| Mindray Ds USA, INC. | $14.38 | 2025 | Te X, Te7 Max |
| Depuy Synthes Sales INC. | $13.63 | 2024 | |
| Conformis, INC. | $7.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.